ARTICLE
7 February 2022

COVID-19 Key EU Developments, Policy & Regulatory Update No. 74

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
This regular update (no. 74 | 24 January 2022) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls;
European Union Coronavirus (COVID-19)

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission approves new and amended Member State measures to support the economy

Trade / Export Controls

  • No noteworthy developments for this issue

Medicines and Medical Devices

  • EMA publishes COVID-19 vaccines safety update
  • European Parliament endorses agreement with Council on reinforced role for EMA crisis preparedness and management for medicinal products and medicinal devices
  • Ministers of Health of EU Member States and EU Commissioner for Health and Food Safety discuss Resilience of Health Systems to Support Cooperation on a European Scale

Cybersecurity, Privacy & Data Protection

  • Council of the European Union adopts Recommendation on a coordinated approach to facilitate safe free movement during COVID-19 pandemic
  • ENISA publishes reports on security of digital identification

To view the full article please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More